These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27411844)

  • 21. PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription.
    Beck DB; Oda H; Shen SS; Reinberg D
    Genes Dev; 2012 Feb; 26(4):325-37. PubMed ID: 22345514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents.
    Cao H; Li L; Yang D; Zeng L; Yewei X; Yu B; Liao G; Chen J
    Eur J Med Chem; 2019 Oct; 179():537-546. PubMed ID: 31276898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin.
    Driskell I; Oda H; Blanco S; Nascimento E; Humphreys P; Frye M
    EMBO J; 2012 Feb; 31(3):616-29. PubMed ID: 22117221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop.
    Wakabayashi K; Okamura M; Tsutsumi S; Nishikawa NS; Tanaka T; Sakakibara I; Kitakami J; Ihara S; Hashimoto Y; Hamakubo T; Kodama T; Aburatani H; Sakai J
    Mol Cell Biol; 2009 Jul; 29(13):3544-55. PubMed ID: 19414603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteome identification of proteins interacting with histone methyltransferase SET8.
    Qin Y; Ouyang H; Liu J; Xie Y
    Acta Biochim Biophys Sin (Shanghai); 2013 Apr; 45(4):303-8. PubMed ID: 23419719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Histone Methyltransferase SETD8 Regulates the Expression of Tumor Suppressor Genes via H4K20 Methylation and the p53 Signaling Pathway in Endometrial Cancer Cells.
    Kukita A; Sone K; Kaneko S; Kawakami E; Oki S; Kojima M; Wada M; Toyohara Y; Takahashi Y; Inoue F; Tanimoto S; Taguchi A; Fukuda T; Miyamoto Y; Tanikawa M; Mori-Uchino M; Tsuruga T; Iriyama T; Matsumoto Y; Nagasaka K; Wada-Hiraike O; Oda K; Hamamoto R; Osuga Y
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis of nucleosomal H4K20 methylation by methyltransferase SET8.
    Shi L; Huang L; Long H; Song A; Zhou Z
    FASEB J; 2022 Jun; 36(6):e22338. PubMed ID: 35532550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amide-derived lysine analogues as substrates and inhibitors of histone lysine methyltransferases and acetyltransferases.
    Hintzen JCJ; Merx J; Maas MN; Langens SGHA; White PB; Boltje TJ; Mecinović J
    Org Biomol Chem; 2021 Dec; 20(1):173-181. PubMed ID: 34877957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct interaction between SET8 and proliferating cell nuclear antigen couples H4-K20 methylation with DNA replication.
    Huen MS; Sy SM; van Deursen JM; Chen J
    J Biol Chem; 2008 Apr; 283(17):11073-7. PubMed ID: 18319261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The histone lysine methyltransferase SETD8 regulates angiogenesis through HES-1 in human umbilical vein endothelial cells.
    Choi DK; Kim YK; Park SW; Lee H; Lee S; Kim SA; Kim SJ; Lee J; Kim W; Min SH; Yu JH
    Sci Rep; 2020 Jul; 10(1):12089. PubMed ID: 32694555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights for the design of protein lysine methyltransferase G9a inhibitors.
    Charles MRC; Dhayalan A; Hsieh HP; Coumar MS
    Future Med Chem; 2019 May; 11(9):993-1014. PubMed ID: 31141392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new regulator of the cell cycle: the PR-Set7 histone methyltransferase.
    Wu S; Rice JC
    Cell Cycle; 2011 Jan; 10(1):68-72. PubMed ID: 21200139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II).
    Lenstra DC; Al Temimi AHK; Mecinović J
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1234-1238. PubMed ID: 29519735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of p53 function by SET8-mediated methylation at lysine 382.
    Shi X; Kachirskaia I; Yamaguchi H; West LE; Wen H; Wang EW; Dutta S; Appella E; Gozani O
    Mol Cell; 2007 Aug; 27(4):636-46. PubMed ID: 17707234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.
    Takawa M; Cho HS; Hayami S; Toyokawa G; Kogure M; Yamane Y; Iwai Y; Maejima K; Ueda K; Masuda A; Dohmae N; Field HI; Tsunoda T; Kobayashi T; Akasu T; Sugiyama M; Ohnuma S; Atomi Y; Ponder BA; Nakamura Y; Hamamoto R
    Cancer Res; 2012 Jul; 72(13):3217-27. PubMed ID: 22556262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The histone H4 lysine 20 monomethyl mark, set by PR-Set7 and stabilized by L(3)mbt, is necessary for proper interphase chromatin organization.
    Sakaguchi A; Joyce E; Aoki T; Schedl P; Steward R
    PLoS One; 2012; 7(9):e45321. PubMed ID: 23024815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone methyltransferase KMT5A gene modulates oncogenesis and lipid metabolism of papillary thyroid cancer in vitro.
    Liao T; Wang YJ; Hu JQ; Wang Y; Han LT; Ma B; Shi RL; Qu N; Wei WJ; Guan Q; Xiang J; Chen JY; Sun GH; Li DS; Mu XM; Ji QH
    Oncol Rep; 2018 May; 39(5):2185-2192. PubMed ID: 29512765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer.
    Wada M; Kukita A; Sone K; Hamamoto R; Kaneko S; Komatsu M; Takahashi Y; Inoue F; Kojima M; Honjoh H; Taguchi A; Kashiyama T; Miyamoto Y; Tanikawa M; Tsuruga T; Mori-Uchino M; Wada-Hiraike O; Osuga Y; Fujii T
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using 'biased-privileged' scaffolds to identify lysine methyltransferase inhibitors.
    Kashyap S; Sandler J; Peters U; Martinez EJ; Kapoor TM
    Bioorg Med Chem; 2014 Apr; 22(7):2253-60. PubMed ID: 24650704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A direct label-free MALDI-TOF mass spectrometry based assay for the characterization of inhibitors of protein lysine methyltransferases.
    Guitot K; Drujon T; Burlina F; Sagan S; Beaupierre S; Pamlard O; Dodd RH; Guillou C; Bolbach G; Sachon E; Guianvarc'h D
    Anal Bioanal Chem; 2017 Jun; 409(15):3767-3777. PubMed ID: 28389916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.